Mahidol University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

291

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

8 drugs in development

Approved4

Phase 32

Phase 21

Phase 12

Preclinical3

By Therapeutic Area

top 6

Cardiovascular

318%

Gastroenterology

212%

Infectious Disease

212%

Nephrology

16%

Respiratory

16%

Oncology

16%

R&D Momentum

69/100

Pipeline Velocity

42/100

Trial Completion Rate

94/100

Pipeline Concentration

13/100

Pipeline Freshness

19/100

Strategic Signals

↗Active in Gastroenterology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 14, 2026

Recruiting

Steroid-sparing Regimen With Olanzapine and Ondansetron to Prevent Emesis Caused by High Dose Cisplatin in Solid Cancer Patient : A Single Arm Phase II Study

Jul 8, 2026

Completed

Development of the Smoking Cessation Service System for Communities.

Jul 1, 2026

Completed

Risk Factors for PICC-Related Infection in 994 High-Risk Patients: The Role of Hb Levels and Sampling Frequency-A Retrospective Cohort Study

Earlier

Jun 27, 2026TrialEfficacy of Pilates on Core Stability and Physical Fitness Among Sedentary Individuals

Jun 26, 2026TrialThe Effect of Artificial Intelligence-Based Postural Feedback on Posture Correction in Idiopathic Scoliosis Patients

Jun 24, 2026TrialEffectiveness of Audio-Tactile Performance Technique With Sing-Along Lyrics on Oral Hygiene Instruction to Visually Impaired Individuals: A Matched-Pair Randomized Study

Jun 24, 2026TrialFeasibility Study of Mixed Reality Exergame on Performance and Cortical Outcomes in Healthy Older Adults and People With Mild Cognitive Impairment

Jun 23, 2026TrialEffect of Brief Bronchial Suction on the Quality of Non-Ventilated Lung Collapse and Time to Adequate Surgical Exposure During Uniportal Video-Assisted Thoracoscopic Surgery: a Randomized Patient- and Surgeon-Blinded Trial

2 more events

Apr 1, 2026TrialLemborexant for Sleep and Delirium Prevention in Elderly ICU Patients

Feb 13, 2026TrialHoly Basil in The Treatment of Dyspepsia

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(3 drugs)

—

Cardiovascular(3 drugs)

Gastroenterology(2 drugs)

—

Gastroenterology(2 drugs)

Infectious Disease(2 drugs)

—

Infectious Disease(2 drugs)

Musculoskeletal(1 drug)

—

Musculoskeletal(1 drug)

Nephrology(1 drug)

—

Nephrology(1 drug)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(1 drug)

—

Oncology(1 drug)

Ophthalmology(1 drug)

—

Ophthalmology(1 drug)

Respiratory(1 drug)

—

Respiratory(1 drug)

Unknown / Other(4 drugs)

—

Unknown / Other(4 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)